The Social Health Authority (SHA) has issued a stern warning to hospitals as new contract rules, under the HAKIKA framework, take effect on October 1.

• Existing healthcare provider contracts with SHA will expire at 11:59 p.m. on September 30.
• SHA CEO Mercy Mwangangi is urging all facilities to complete the new contracting process before the deadline to continue serving SHA beneficiaries.
• Facilities without an executed contract for the 2026–2029 cycle will be prohibited from offering services, and their portal access will be deactivated.

Healthcare providers and facilities under the Social Health Authority (SHA) must renew their contracts by Wednesday, September 30, 2026, to continue offering services to beneficiaries.

• Current SHA provider contracts expire on September 30, 2026.
• The Social Health Authority (SHA), led by CEO Dr. Mercy Mwangangi, is enforcing the contract renewal deadline.
• Providers failing to secure a new contract for the 2026–2029 cycle risk losing access to the SHA provider portal and must arrange patient transfers.

The Social Health Authority (SHA) has updated its verification schedule for healthcare facilities with pending claims exceeding Ksh10 million from the former National Health Insurance Fund (NHIF).

• Facilities with pending claims of Ksh10 million and above are affected.
• The Social Health Authority (SHA) is conducting the verification.
• This comes as existing SHA contracts for providers expire on September 30, 2026.

Kenya is bolstering its local pharmaceutical production and regulatory frameworks to enhance health security and reduce reliance on imports across Africa. This initiative aims to expand access to quality health products and build more resilient health systems on the continent.

• Kenya aims to achieve 50% local production of essential health products by 2030.
• Key figures include Cabinet Secretary for Health Aden Duale and the Pharmacy and Poisons Board.
• The country is also working towards WHO Maturity Level 3 for its regulatory system, with 13 new pharmaceutical companies already operational.